Patents by Inventor Steven E. LAZAR

Steven E. LAZAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230321145
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including nonhealing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Application
    Filed: December 7, 2022
    Publication date: October 12, 2023
    Inventors: Matthew B. Dowling, Steven E. Lazar, Helga M. Gentile
  • Patent number: 11534459
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: December 27, 2022
    Assignee: EYE CARE INTERNATIONAL, LLC
    Inventors: Matthew B. Dowling, Steven E. Lazar, Helga M. Gentile
  • Publication number: 20220168341
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Application
    Filed: November 9, 2021
    Publication date: June 2, 2022
    Inventors: Matthew B. Dowling, Steven E. Lazar, Helga M. Gentile
  • Patent number: 11191781
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: December 7, 2021
    Assignee: Eye Care International, LLC
    Inventors: Matthew B. Dowling, Steven E. Lazar, Helga M. Gentile
  • Publication number: 20190175647
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Application
    Filed: June 16, 2017
    Publication date: June 13, 2019
    Applicant: Eye Care International, LLC
    Inventors: Matthew B. DOWLING, Steven E. LAZAR, Helga M. GENTILE